Announce Date | 07/24/2025 |
EPS Normalized Actual | $0.12 (Beat by $0.02) |
EPS GAAP Actual | $0.12 (Beat by $0.02) |
Revenue Actual | $1.884B |
Revenue Surprise | Beat by $1884M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.34715 |
EPS GAAP Estimate | $0.34715 |
Revenue Estimate | $2.150029275B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 1.88 | 13.74 | 1.7854 | 1.97469 | 1 |
Dec 2027 | 1.63 | 15.85 | 1.54798 | 1.7121 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.12 | -0.2273 | 1.884B | -2.92% | -253.15M |
FQ1 2025 (Mar 2025) | 0.11 | 0.11 | 0.335B | -866.27% | 335M |
FQ4 2024 (Dec 2024) | 0.11 | 0.11 | 1.708B | -3.86% | 1708M |
FQ3 2024 (Sep 2024) | 0.04 | 0.04 | 3.112B | -13.82% | 3112M |
FQ2 2024 (Jun 2024) | 0.24 | 0.24 | 1.939B | -2.99% | 1939M |
FQ1 2024 (Mar 2024) | 0.0002 | 0.0002 | 3.237B | 41.89% | 3237M |
FQ4 2023 (Dec 2023) | 0.3 | 0.3 | 1.774B | -2.76% | 1774M |
FQ3 2023 (Sep 2023) | 0.33 | 0.33 | 3.542B | 99.94% | 3542M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.34715
Consensus Revenue Estimates
2.150029275B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.26 | -- | 0.2528 | 0.26919 | 3 |
FQ3 2027 (Sep 2027) | 0.39 | -- | 0.37921 | 0.40378 | 3 |
FQ2 2027 (Jun 2027) | 0.42 | -- | 0.40838 | 0.43484 | 3 |
FQ1 2027 (Mar 2027) | 0.38 | -- | 0.36948 | 0.39343 | 3 |
FQ4 2026 (Oct 2026) | 0.4389 | -- | 0.42163 | 0.46086 | 3 |
FQ3 2026 (Jul 2026) | 0.4459 | -- | 0.42835 | 0.46821 | 4 |
FQ2 2026 (Jun 2026) | 0.4459 | 73.09 | 0.42519 | 0.47563 | 4 |
FQ1 2026 (Mar 2026) | 0.3195 | 65.57 | 0.30466 | 0.3408 | 5 |
FQ4 2025 (Oct 2025) | 0.3547 | 68.99 | 0.34074 | 0.37244 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.01B | -- | 1.97B | 2.06B | 2 |
FQ3 2027 (Sep 2027) | 2.18B | -- | 2.13B | 2.24B | 2 |
FQ2 2027 (Jun 2027) | 2.25B | -- | 2.2B | 2.31B | 2 |
FQ1 2027 (Mar 2027) | 2.09B | -- | 2.05B | 2.15B | 2 |
FQ4 2026 (Oct 2026) | 2.25B | -- | 2.18B | 2.34B | 4 |
FQ3 2026 (Jul 2026) | 2.29B | -- | 2.22B | 2.37B | 4 |
FQ2 2026 (Jun 2026) | 2.29B | 17.6 | 2.2B | 2.4B | 4 |
FQ1 2026 (Mar 2026) | 2.04B | 83.59 | 1.97B | 2.15B | 4 |
FQ4 2025 (Oct 2025) | 2.13B | 19.95 | 2.07B | 2.22B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.3473 | 0.12 | -0.2273 | -189.42% |
FQ1 2025 (Mar 2025) | 0.11 | 0.11 | 100% | |
FQ4 2024 (Dec 2024) | 0.11 | 0.11 | 100% | |
FQ3 2024 (Sep 2024) | 0.04 | 0.04 | 100% | |
FQ2 2024 (Jun 2024) | 0.24 | 0.24 | 100% | |
FQ1 2024 (Mar 2024) | 0.0002 | 0.0002 | 100% | |
FQ4 2023 (Dec 2023) | 0.3 | 0.3 | 100% | |
FQ3 2023 (Sep 2023) | 0.33 | 0.33 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $2.14B | $1.88B | $-253.15M | -13.44% |
FQ1 2025 (Mar 2025) | $0B | $0.34B | $335M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.71B | $1708M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.11B | $3112M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.94B | $1939M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.24B | $3237M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.77B | $1774M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.54B | $3542M | 100% |